Local PPO · observed 2026 → 2026 · 39 months of CPSC history · 17 active CY 2026 plans.
| Plan | Category | Premium | MOOP | ★ | Counties | Enrollment |
|---|---|---|---|---|---|---|
| Aetna Medicare Elite (PPO) H2293/031 | MA-PD | $0 | $9,250 | 4.0 | 120 | 23,964 |
| Aetna Medicare Signature (PPO) H2293/016 | MA-PD | $0 | $6,750 | 4.0 | 16 | 15,914 |
| Aetna Medicare Dual Extra Care (PPO D-SNP) H2293/002 · Dual-Eligible | SNP | $14 | $9,250 | 4.0 | 157 | 14,095 |
| Aetna Medicare Value Care (PPO) H2293/001 | MA-PD | $25 | $9,250 | 4.0 | 108 | 10,028 |
| Aetna Medicare Dual Extra (PPO D-SNP) H2293/021 · Dual-Eligible | SNP | $11 | $9,250 | 4.0 | 108 | 8,539 |
| Aetna Medicare Signature Extra (PPO) H2293/014 | MA-PD | $0 | $6,750 | 4.0 | 33 | 8,093 |
| Aetna Medicare Signature Care (PPO) H2293/029 | MA-PD | $0 | $9,250 | 4.0 | 24 | 4,917 |
| Aetna Medicare Value Care (PPO) H2293/023 | MA-PD | $25 | $9,250 | 4.0 | 37 | 4,865 |
| Aetna Medicare Elite Giveback (PPO) H2293/010 | MA-PD | $0 | $9,250 | 4.0 | 18 | 4,214 |
| Aetna Medicare Dual Care (PPO D-SNP) H2293/004 · Dual-Eligible | SNP | $15 | $9,250 | 4.0 | 53 | 3,699 |
| Aetna Medicare Signature (PPO) H2293/019 | MA-PD | $0 | $6,750 | 4.0 | 8 | 3,672 |
| Aetna Medicare Chronic Care (PPO C-SNP) H2293/035 · Chronic or Disabling Condition | SNP | $0 | $9,250 | 4.0 | 14 | 3,399 |
| Aetna Medicare Signature (PPO) H2293/017 | MA-PD | $0 | $6,750 | 4.0 | 5 | 3,169 |
| Aetna Medicare Value Plus (PPO) H2293/033 | MA-PD | $21 | $9,250 | 4.0 | 35 | 2,954 |
| Aetna Medicare Eagle Plus (PPO) H2293/009 | MA | — | $8,900 | 4.0 | 157 | 1,353 |
| Aetna Medicare Signature (PPO) H2293/026 | MA-PD | $0 | $6,750 | 4.0 | 2 | 1,260 |
| Aetna Medicare Enhanced (PPO) H2293/025 | MA-PD | $50 | $6,750 | 4.0 | 8 | 492 |
| ID | Measure | ★ |
|---|---|---|
| C01 | Breast Cancer Screening | 4.0 |
| C02 | Colorectal Cancer Screening | 4.0 |
| C03 | Annual Flu Vaccine | 3.0 |
| C04 | Improving or Maintaining Physical Health | — |
| C05 | Improving or Maintaining Mental Health | — |
| C06 | Monitoring Physical Activity | 3.0 |
| C07 | Special Needs Plan (SNP) Care Management | 3.0 |
| C08 | Care for Older Adults – Medication Review | 5.0 |
| C09 | Care for Older Adults – Pain Assessment | 5.0 |
| C10 | Osteoporosis Management in Women who had a Fracture | 4.0 |
| C11 | Diabetes Care – Eye Exam | 3.0 |
| C12 | Diabetes Care – Blood Sugar Controlled | 5.0 |
| C13 | Kidney Health Evaluation for Patients with Diabetes | 3.0 |
| C14 | Controlling High Blood Pressure | 3.0 |
| C15 | Reducing the Risk of Falling | 2.0 |
| C16 | Improving Bladder Control | 1.0 |
| C17 | Medication Reconciliation Post-Discharge | 5.0 |
| C18 | Plan All-Cause Readmissions | 4.0 |
| C19 | Statin Therapy for Patients with Cardiovascular Disease | 3.0 |
| C20 | Transitions of Care | 3.0 |
| C21 | Follow-up after Emergency Department Visit for People with Multiple High-Risk Chronic Conditions | 4.0 |
| C22 | Getting Needed Care | 5.0 |
| C23 | Getting Appointments and Care Quickly | 4.0 |
| C24 | Customer Service | 3.0 |
| C25 | Rating of Health Care Quality | 4.0 |
| C26 | Rating of Health Plan | 4.0 |
| C27 | Care Coordination | 4.0 |
| C28 | Complaints about the Health Plan | 4.0 |
| C29 | Members Choosing to Leave the Plan | 4.0 |
| C30 | Health Plan Quality Improvement | 4.0 |
| C31 | Plan Makes Timely Decisions about Appeals | 4.0 |
| C32 | Reviewing Appeals Decisions | 4.0 |
| C33 | Call Center – Foreign Language Interpreter and TTY Availability | 4.0 |
| D01 | Call Center – Foreign Language Interpreter and TTY Availability | 5.0 |
| D02 | Complaints about the Drug Plan | 4.0 |
| D03 | Members Choosing to Leave the Plan | 4.0 |
| D04 | Drug Plan Quality Improvement | 4.0 |
| D05 | Rating of Drug Plan | 4.0 |
| D06 | Getting Needed Prescription Drugs | 4.0 |
| D07 | MPF Price Accuracy | 5.0 |
| D08 | Medication Adherence for Diabetes Medications | 2.0 |
| D09 | Medication Adherence for Hypertension (RAS antagonists) | 4.0 |
| D10 | Medication Adherence for Cholesterol (Statins) | 4.0 |
| D11 | MTM Program Completion Rate for CMR | 5.0 |
| D12 | Statin Use in Persons with Diabetes (SUPD) | 3.0 |
No incoming transitions for this contract.